These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20717756)

  • 1. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
    Li F; Zeng H; Ying K
    Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer.
    Herpel E; Jensen K; Muley T; Warth A; Schnabel PA; Meister M; Herth FJ; Dienemann H; Thomas M; Gottschling S
    Anticancer Res; 2011 Dec; 31(12):4491-500. PubMed ID: 22199321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
    Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
    Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
    Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.
    Gottschling S; Jensen K; Herth FJ; Thomas M; Schnabel PA; Herpel E
    Anticancer Res; 2013 Mar; 33(3):981-90. PubMed ID: 23482770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of tumor stem cell markers in pancreatic carcinoma cell lines.
    Olempska M; Eisenach PA; Ammerpohl O; Ungefroren H; Fandrich F; Kalthoff H
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):92-7. PubMed ID: 17287174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma.
    Li W; Tamamura R; Wang B; Liu Q; Liu H; Liu T; Katase N; Xiao J; Nagatsuka H
    Biomed Res Int; 2014; 2014():132349. PubMed ID: 24804195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
    Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review.
    Qu H; Li R; Liu Z; Zhang J; Luo R
    Int J Clin Exp Pathol; 2013; 6(11):2644-50. PubMed ID: 24228135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of circulating CD133(+) cells in patients with gastric cancer.
    Xia P; Song CL; Liu JF; Wang D; Xu XY
    Cell Prolif; 2015 Jun; 48(3):311-7. PubMed ID: 25727099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
    Alamgeer M; Ganju V; Szczepny A; Russell PA; Prodanovic Z; Kumar B; Wainer Z; Brown T; Schneider-Kolsky M; Conron M; Wright G; Watkins DN
    Thorax; 2013 Dec; 68(12):1095-104. PubMed ID: 23878161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q; Zhang X; Deng T; Gao J
    Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.
    Wu S; Yu L; Wang D; Zhou L; Cheng Z; Chai D; Ma L; Tao Y
    BMC Cancer; 2012 Nov; 12():535. PubMed ID: 23170850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.
    Chen YC; Hsu HS; Chen YW; Tsai TH; How CK; Wang CY; Hung SC; Chang YL; Tsai ML; Lee YY; Ku HH; Chiou SH
    PLoS One; 2008 Jul; 3(7):e2637. PubMed ID: 18612434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
    Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
    Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.